Literature DB >> 15699053

Evidence for the involvement of cytosolic 5'-nucleotidase (cN-II) in the synthesis of guanine nucleotides from xanthosine.

Catia Barsotti1, Rossana Pesi, Michela Giannecchini, Piero L Ipata.   

Abstract

In this paper, we show that in vitro xanthosine does not enter any of the pathways known to salvage the other three main natural purine nucleosides: guanosine; inosine; and adenosine. In rat brain extracts and in intact LoVo cells, xanthosine is salvaged to XMP via the phosphotransferase activity of cytosolic 5'-nucleotidase. IMP is the preferred phosphate donor (IMP + xanthosine --> XMP + inosine). XMP is not further phosphorylated. However, in the presence of glutamine, it is readily converted to guanyl compounds. Thus, phosphorylation of xanthosine by cytosolic 5'-nucleotidase circumvents the activity of IMP dehydrogenase, a rate-limiting enzyme, catalyzing the NAD(+)-dependent conversion of IMP to XMP at the branch point of de novo nucleotide synthesis, thus leading to the generation of guanine nucleotides. Mycophenolic acid, an inhibitor of IMP dehydrogenase, inhibits the guanyl compound synthesis via the IMP dehydrogenase pathway but has no effect on the cytosolic 5'-nucleotidase pathway of guanine nucleotides synthesis. We propose that the latter pathway might contribute to the reversal of the in vitro antiproliferative effect exerted by IMP dehydrogenase inhibitors routinely seen with repletion of the guanine nucleotide pools.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699053     DOI: 10.1074/jbc.M413347200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Profiles of purine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.

Authors:  Riko Katahira; Hiroshi Ashihara
Journal:  Planta       Date:  2006-07-15       Impact factor: 4.116

2.  Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma.

Authors:  Guisheng Zhao; Patrick Newbury; Yukitomo Ishi; Eugene Chekalin; Billy Zeng; Benjamin S Glicksberg; Anita Wen; Shreya Paithankar; Takahiro Sasaki; Amreena Suri; Javad Nazarian; Michael E Pacold; Daniel J Brat; Theodore Nicolaides; Bin Chen; Rintaro Hashizume
Journal:  Acta Neuropathol Commun       Date:  2022-10-23       Impact factor: 7.578

3.  Opioid use affects antioxidant activity and purine metabolism: preliminary results.

Authors:  Paolo Mannelli; Ashwin Patkar; Steve Rozen; Wayne Matson; Ranga Krishnan; Rima Kaddurah-Daouk
Journal:  Hum Psychopharmacol       Date:  2009-12       Impact factor: 1.672

4.  Nucleoside map of the human central nervous system.

Authors:  Zsolt Kovács; Arpád Dobolyi; Gábor Juhász; Katalin A Kékesi
Journal:  Neurochem Res       Date:  2009-10-24       Impact factor: 3.996

5.  Recent advances in structure and function of cytosolic IMP-GMP specific 5'-nucleotidase II (cN-II).

Authors:  Piero Luigi Ipata; Maria Grazia Tozzi
Journal:  Purinergic Signal       Date:  2006-06-29       Impact factor: 3.765

6.  Large-scaled metabolic profiling of human dermal fibroblasts derived from pseudoxanthoma elasticum patients and healthy controls.

Authors:  Patricia Kuzaj; Joachim Kuhn; Ryan D Michalek; Edward D Karoly; Isabel Faust; Mareike Dabisch-Ruthe; Cornelius Knabbe; Doris Hendig
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

7.  Human liver rate-limiting enzymes influence metabolic flux via branch points and inhibitors.

Authors:  Min Zhao; Hong Qu
Journal:  BMC Genomics       Date:  2009-12-03       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.